PRIMARY BILIARY CHOLANGITIS
Clinical trials for PRIMARY BILIARY CHOLANGITIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CHOLANGITIS trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CHOLANGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial offers hope for liver disease patients
Disease control OngoingThis study is testing whether a daily medication called elafibranor can help normalize liver enzyme levels in adults with primary biliary cholangitis (PBC), a chronic liver disease. Participants who haven't responded well to standard treatment will be randomly assigned to receive…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for stubborn liver disease: trial tests Second-Line drug
Disease control OngoingThis study is testing whether a drug called pemafibrate (K-808) can help control primary biliary cholangitis (PBC), a chronic liver disease, in people whose liver tests remain high despite taking standard medications. About 46 adults who haven't responded well to their current PB…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE2 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New hope for controlling rare liver disease in japanese patients
Disease control OngoingThis study is testing whether a daily pill called elafibranor can help control primary biliary cholangitis (PBC), a rare liver disease that damages bile ducts. It will involve about 18 Japanese adults whose current treatment isn't working well enough. Researchers will check if th…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug combo trial offers hope for liver disease patients
Disease control OngoingThis study tested whether adding fenofibrate to the standard treatment (ursodeoxycholic acid) helps people with primary biliary cholangitis, a chronic liver disease. Researchers measured whether the combination improves liver blood tests and reduces symptoms like itching and fati…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE2, PHASE3 • Sponsor: Han Ying • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Wrist sensor tracks nighttime itch in rare liver disease
Knowledge-focused OngoingThis study aims to better understand two common and disruptive symptoms of Primary Biliary Cholangitis (PBC): itching and poor sleep. Researchers will use a special wrist-worn sensor called ADAM to automatically measure how often and how intensely 30 participants scratch in their…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Sponsor: Ipsen • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:24 UTC